四环生物,000518,收入构成,报告日期,2021-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 用材林,1088,-- ,-- ,--,0% 养护工程,142,-- ,-- ,--,0% 其他(补充),-- ,254,-- ,--,0% 其他,714,-- ,-- ,--,0% 苗木,318,-- ,-- ,--,0% 景观工程,4340,-- ,-- ,--,0% 白介素,10009,922,9088,90.79%,41.01% G-CSF,5124,809,4315,84.21%,19.47% EPO,13362,4607,8755,65.52%,39.51% 四环生物,000518,收入构成,报告日期,2021-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 租赁,33,-- ,-- ,--,0% 用材林,1088,-- ,-- ,--,0% 其他(补充),-- ,40,-- ,--,0% 其他,182,-- ,-- ,--,0% 苗木,310,-- ,-- ,--,0% 景观工程,766,-- ,-- ,--,0% 白介素,4871,387,4484,92.06%,44% G-CSF,1993,317,1676,84.1%,16.45% EPO,5732,1702,4030,70.31%,39.55% 四环生物,000518,收入构成,报告日期,2020-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 用材林,14385,-- ,-- ,--,0% 养护工程,170,-- ,-- ,--,0% 其他(补充),-- ,89,-- ,--,0% 其他,442,-- ,-- ,--,0% 苗木,1668,-- ,-- ,--,0% 景观工程,3351,-- ,-- ,--,0% 白介素,11187,1050,10137,90.61%,41.32% G-CSF,5484,871,4614,84.13%,18.81% EPO,13853,4069,9783,70.62%,39.88% 四环生物,000518,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),-- ,51,-- ,--,0% 其他,173,-- ,-- ,--,0% 租赁,55,-- ,-- ,--,0% 苗木,122,-- ,-- ,--,0% 景观工程,260,-- ,-- ,--,0% 用材林,10547,7317,3230,30.62%,23.56% 医疗用品,19,-- ,-- ,--,0% G-CSF,2067,263,1805,87.3%,13.17% EPO,6014,1410,4604,76.55%,33.59% 白介素,4399,330,4069,92.5%,29.69% 四环生物,000518,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 景观工程,2816,-- ,-- ,--,0% 白介素,13244,955,12288,92.79%,42.47% 养护工程,121,-- ,-- ,--,0% EPO,14163,3270,10892,76.91%,37.64% 其他(补充),609,93,516,84.73%,1.78% 苗木,1974,-- ,-- ,--,0% G-CSF,5828,587,5240,89.92%,18.11% 用材林,3034,-- ,-- ,--,0% 四环生物,000518,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 景观工程,422,323,99,23.55%,0.78% EPO,5956,1439,4517,75.83%,35.47% 白介素,5540,456,5084,91.77%,39.93% 其他(补充),186,42,144,77.56%,1.13% 用材林,918,696,223,24.26%,1.75% 苗木,1972,1458,514,26.05%,4.03% G-CSF,2404,251,2153,89.55%,16.91% 四环生物,000518,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),248,89,159,63.99%,0.53% 养护工程,141,74,67,47.35%,0.23% EPO,13992,3225,10767,76.95%,36.23% G-CSF,3905,396,3509,89.86%,11.81% 用材林,4241,3765,476,11.22%,1.6% 景观工程,1363,1066,297,21.81%,1% 白介素,15522,1094,14428,92.96%,48.56% 苗木,139,127,12,8.33%,0.04% 四环生物,000518,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 景观工程,575,509,66,11.48%,0.48% EPO,6531,1520,5011,76.73%,36.6% G-CSF,1710,191,1518,88.8%,11.09% 用材林,1801,1574,227,12.62%,1.66% 白介素,7353,556,6797,92.44%,49.65% 苗木,9,7,2,25.58%,0.02% 其他(补充),111,43,68,61.35%,0.5% 四环生物,000518,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 用材林,1307,1085,222,16.99%,0.89% 糖浆剂,161,-- ,-- ,--,0% 片剂,2003,-- ,-- ,--,0% 其他(补充),755,439,315,41.78%,1.26% 养护工程收入,130,74,55,42.58%,0.22% 白介素,14918,1273,13645,91.47%,54.43% 苗木,56,7,49,86.88%,0.19% 软袋输液,580,-- ,-- ,--,0% 保健品,317,-- ,-- ,--,0% EPO,11064,2704,8360,75.56%,33.35% 原料药,430,-- ,-- ,--,0% G-CSF,2843,420,2422,85.22%,9.66% 玻瓶输液,42,-- ,-- ,--,0% 四环生物,000518,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),350,79,272,77.51%,2.37% 桉树,1473,875,598,40.59%,5.22% 景观苗木,1902,1409,493,25.92%,4.3% 糖浆剂,164,114,50,30.47%,0.43% 软袋输液,580,639,-59,-10.1%,-0.51% 玻瓶输液,42,35,7,17.16%,0.06% 原料药,430,275,156,36.18%,1.36% 保健品,317,307,10,3.19%,0.09% 片剂,2003,928,1076,53.7%,9.39% G-CSF,1067,183,884,82.87%,7.71% EPO,4569,1131,3438,75.25%,30% 白介素,4937,401,4536,91.88%,39.58% 四环生物,000518,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),405,95,311,76.61%,1.48% 苗木,0,-- ,-- ,--,0% 养护工程收入,142,-- ,-- ,--,0% 景观工程收入,601,-- ,-- ,--,0% 糖浆剂,425,223,201,47.43%,0.96% 软袋输液,1607,709,898,55.89%,4.27% 玻瓶输液,259,214,46,17.59%,0.22% 原料药,1856,845,1011,54.46%,4.81% 保健品,881,495,387,43.86%,1.84% 片剂,3537,2268,1269,35.89%,6.04% G-CSF,2010,-- ,-- ,--,0% EPO,8721,2759,5962,68.37%,28.37% 白介素,12286,1357,10929,88.96%,52.01% 四环生物,000518,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),174,54,120,68.89%,1.47% 糖浆剂,216,149,68,31.3%,0.83% 软袋输液,809,696,113,13.97%,1.38% 玻瓶输液,28,20,8,27.24%,0.09% 原料药,1016,639,377,37.1%,4.62% 保健品,294,246,49,16.62%,0.6% 片剂,1379,1049,330,23.93%,4.04% G-CSF,832,193,639,76.84%,7.82% EPO,3883,1243,2640,67.99%,32.33% 白介素,4343,519,3824,88.05%,46.82% 四环生物,000518,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他业务收入,508,86,422,83.12%,3.26% 苗木,248,-- ,-- ,--,0% 糖浆剂,541,-- ,-- ,--,0% 软袋输液,1570,-- ,-- ,--,0% 玻瓶输液,161,-- ,-- ,--,0% 针剂,0,-- ,-- ,--,0% 原料药,210,-- ,-- ,--,0% 保健品,588,-- ,-- ,--,0% 片剂,4044,2610,1434,35.47%,11.06% G-CSF,1628,-- ,-- ,--,0% EPO,7070,2186,4885,69.08%,37.65% 白介素,7217,986,6231,86.34%,48.03% 四环生物,000518,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 软袋输液,844,622,222,26.32%,3.24% 保健品,221,200,21,9.47%,0.3% 糖浆剂,257,189,68,26.47%,0.99% 原料药,101,83,18,18.21%,0.27% G-CSF,1519,208,1311,86.33%,19.11% 其他(补充),268,63,205,76.55%,2.99% 玻瓶输液,64,40,25,38.29%,0.36% 片剂,1550,1067,483,31.16%,7.04% 白介素,2639,504,2136,80.92%,31.13% EPO,3406,1035,2371,69.62%,34.56% 四环生物,000518,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 软袋输液,2164,1376,788,36.4%,5.51% 原料药,1056,951,105,9.97%,0.74% G-CSF,2234,581,1654,74%,11.56% EPO,7391,2260,5131,69.43%,35.88% 其他(补充),656,82,574,87.54%,4.01% 玻瓶输液,291,233,58,19.99%,0.41% 保健品,487,490,-3,-0.57%,-0.02% 糖浆剂,520,403,117,22.55%,0.82% 针剂,9,10,-2,-18.71%,-0.01% 片剂,3412,2369,1043,30.58%,7.3% 白介素,5903,1068,4836,81.91%,33.81% 四环生物,000518,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),246,-- ,-- ,--,0% 糖浆剂,96,67,29,29.84%,0.38% 软袋输液,1167,719,448,38.37%,5.98% 玻瓶输液,231,169,62,26.74%,0.82% 针剂,5,7,-2,-41.41%,-0.03% 原料药,801,740,60,7.55%,0.81% 保健品,115,133,-18,-15.26%,-0.23% 片剂,2014,1385,629,31.23%,8.4% G-CSF,1212,325,887,73.18%,11.84% EPO,3917,1271,2645,67.54%,35.31% 白介素,3377,626,2751,81.46%,36.72% 四环生物,000518,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),487,67,420,86.18%,4% 保健品,1468,856,612,41.69%,5.83% 糖浆剂,467,221,246,52.61%,2.34% 针剂,267,269,-3,-1.11%,-0.03% 软袋输液,3277,1941,1336,40.76%,12.73% 玻瓶输液,1466,1265,202,13.75%,1.92% 原料药,1565,1402,163,10.4%,1.55% 片剂,2999,2160,839,27.98%,8% G-CSF,1098,365,733,66.74%,6.98% EPO,4429,1188,3241,73.18%,30.89% 白介素,3351,648,2703,80.67%,25.77% 四环生物,000518,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),82,-- ,-- ,--,0% 糖浆剂,59,52,8,12.86%,0.14% 软袋输液,1903,1089,813,42.74%,14.95% 玻瓶输液,740,633,107,14.4%,1.96% 针剂,245,296,-51,-20.69%,-0.93% 原料药,722,639,83,11.51%,1.53% 保健品,133,148,-15,-10.9%,-0.27% 片剂,1543,1159,384,24.91%,7.06% G-CSF,703,183,521,74.03%,9.57% EPO,2540,681,1859,73.18%,34.17% 白介素,2086,355,1731,82.96%,31.82% 四环生物,000518,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),763,67,697,91.26%,5.43% 广告费,0,0,0,--,0% 保健品,502,422,80,15.96%,0.62% 糖浆剂,211,186,24,11.53%,0.19% 针剂,599,751,-152,-25.33%,-1.18% 软袋输液,3992,2677,1315,32.94%,10.25% 玻瓶输液,2089,1746,343,16.42%,2.67% 原料药,2047,1881,166,8.09%,1.29% 片剂,2958,2150,808,27.31%,6.3% G-CSF,1901,577,1324,69.65%,10.32% EPO,5699,2020,3680,64.56%,28.68% 白介素,5486,941,4545,82.84%,35.43% 四环生物,000518,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 广告传媒,0,0,0,--,0% 软袋输液,2035,1242,793,38.96%,15.01% 保健品,249,204,45,18.21%,0.86% G-CSF,731,244,487,66.62%,9.21% 白介素,2483,433,2050,82.58%,38.8% 针剂,206,319,-113,-54.7%,-2.14% 玻瓶输液,976,808,168,17.18%,3.17% 原料药,826,776,51,6.14%,0.96% 其他(补充),209,-- ,-- ,--,0% 片剂,1154,928,226,19.55%,4.27% EPO,2603,1022,1581,60.75%,29.93% 糖浆剂,38,42,-4,-10.34%,-0.07% 四环生物,000518,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 广告传媒,332,0,332,100%,2.82% 医药,23059,12216,10843,47.02%,92.26% 其他(补充),1023,445,578,56.49%,4.92% 四环生物,000518,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),174,2,172,98.74%,2.99% 广告传媒,332,0,332,100%,5.77% 医药,11221,5968,5253,46.82%,91.25% 四环生物,000518,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),89,72,17,18.81%,0.56% 白介素2,1580,243,1337,84.61%,44.87% 欣粒生G-CSF,797,224,573,71.9%,19.24% EPO,1666,614,1052,63.17%,35.33% 四环生物,000518,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 呲嗪酰胺原料,1005,954,51,5.08%,1.11% EPO,3227,1343,1884,58.37%,40.93% 白介素,3210,543,2668,83.1%,57.96% 四环生物,000518,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 原料,707,687,19,2.72%,0.61% 针剂,371,393,-22,-5.82%,-0.68% 片剂,486,343,143,29.34%,4.5% 软袋输液,1685,1038,647,38.4%,20.43% 输液(瓶),861,663,198,22.97%,6.24% 欣粒生G-CSF,522,184,338,64.81%,10.68% EPO,1387,593,794,57.28%,25.08% 重组人白介素-2,1294,244,1050,81.13%,33.14% 四环生物,000518,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 250ml生理盐水(软袋),868,517,351,40.46%,6.97% 250ml15%葡萄糖输液(软袋),891,50,841,94.36%,16.69% 欣粒生G-CSF,1481,694,787,53.14%,15.62% EPO,2070,914,1156,55.84%,22.94% 白介素,2647,743,1904,71.92%,37.78% 四环生物,000518,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 EPO,881,413,468,53.15%,21.67% 输液(瓶),1050,889,162,15.38%,7.48% 重组人白介素-2,1247,463,783,62.84%,36.26% 软袋输液,1899,1152,747,39.35%,34.6% 四环生物,000518,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 重组人白介素-2,1381,649,732,52.98%,56.05% 顺毛大衣呢,2004,1507,498,24.82%,38.11% 全毛花呢,2054,1978,76,3.71%,5.84% 四环生物,000518,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 重组人白介素-2,899,447,451,50.23%,61.03% 全毛花呢坯布,2507,2218,288,11.5%,38.97% 四环生物,000518,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药,8457,5990,2468,29.18%,31.06% 毛纺织品,19651,14174,5478,27.87%,68.94% 四环生物,000518,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 白介素-2,1587,965,622,39.17%,28.05% 羊绒大衣呢,4294,2700,1594,37.12%,71.95% 四环生物,000518,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 重组人白介素-2,1047,637,410,39.13%,25.19% 羊绒大衣呢,3063,1846,1217,39.73%,74.81% 四环生物,000518,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药产品,1891,1299,593,31.35%,45.66% 毛纺织品,2798,2093,706,25.21%,54.34% 四环生物,000518,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药,7132,4774,2357,33.06%,68.2% 毛纺织品,13442,12343,1099,8.18%,31.8% 四环生物,000518,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 白介素-2,1312,829,484,36.86%,59.68% 纯羊绒大衣呢,1674,1348,327,19.51%,40.32% 四环生物,000518,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 重组人白介素-2,985,638,347,35.25%,53.89% 纯羊绒大衣呢,1410,1113,297,21.08%,46.11% 四环生物,000518,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药产品,1898,783,1115,58.74%,28.37% 毛纺织品,3435,619,2815,81.97%,71.63% 四环生物,000518,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药,7712,4137,3576,46.36%,39.84% 毛纺织品,23436,18037,5399,23.04%,60.16% 四环生物,000518,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药产品,7534,0,7534,100%,30.02% 毛纺织品,17560,0,17560,100%,69.98% 四环生物,000518,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 重组人白介素-2,2624,645,1979,75.41%,51.04% 全毛花呢,6465,4567,1898,29.35%,48.96% 四环生物,000518,收入构成,报告日期,2004-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药产品,4702,3263,1439,30.6%,20.76% 毛纺织品,8290,2797,5493,66.26%,79.24% 四环生物,000518,收入构成,报告日期,2003-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药,10273,4760,5513,53.67%,41.62% 毛纺织品,27294,19562,7732,28.33%,58.38% 四环生物,000518,收入构成,报告日期,2003-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药产品,8187,3775,4412,53.89%,40.11% 毛纺织品,21814,15226,6588,30.2%,59.89% 四环生物,000518,收入构成,报告日期,2003-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 IL-2,3436,1264,2173,63.22%,41.79% 全毛花呢,9651,6625,3026,31.36%,58.21% 四环生物,000518,收入构成,报告日期,2003-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药产品,2481,1257,1224,49.34%,27.76% 毛纺织品,9267,6082,3185,34.37%,72.24% 四环生物,000518,收入构成,报告日期,2002-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药,11801,5387,6414,54.35%,45.89% 毛纺织品,35207,27643,7564,21.48%,54.11% 四环生物,000518,收入构成,报告日期,2001-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药,1529,810,719,47.01%,5.65% 毛纺织品,35147,23147,11999,34.14%,94.35%